Information on purchasing Inqovi (decitabine and cedazuridine) is available through prescription. Patients interested in buying Inqovi should consult with their healthcare provider or a qualified medical professional who can assess their treatment needs and provide a prescription if appropriate. Pharmacies can then fill this prescription.
Where can I get Inqovi if my doctor prescribes it?
If your healthcare provider prescribes Inqovi, you will typically obtain it from a specialty pharmacy. Your doctor's office or a patient support program may be able to assist you in locating a pharmacy that dispenses Inqovi and navigating the prescription fulfillment process.
What is Inqovi used to treat?
Inqovi is a combination medication used for the treatment of adults with myelodysplastic syndromes (MDS), including certain types of chronic myelomonocytic leukemia (CMML) [1]. MDS are a group of blood cancers that affect the bone marrow's ability to produce healthy blood cells.
How does Inqovi work?
Inqovi combines decitabine, a hypomethylating agent, with cedazuridine, an inhibitor of cytidine deaminase [1]. Decitabine works by reducing DNA methylation, which can help restore normal gene function and inhibit the growth of cancer cells. Cedazuridine is included to increase the oral bioavailability of decitabine, allowing it to be taken by mouth rather than through injection.
What are the potential side effects of Inqovi?
Common side effects of Inqovi can include low blood cell counts (neutropenia, anemia, thrombocytopenia), fatigue, constipation, diarrhea, nausea, and pneumonia [1]. It is important to discuss any potential side effects with your healthcare provider.
When does the patent for Inqovi expire?
Information regarding the patent expiration for Inqovi is complex and subject to change. Pharmaceutical patent landscapes can involve multiple patents covering the drug substance, formulation, and methods of use. For detailed and up-to-date patent information, including potential expiration dates and any ongoing patent litigations, consulting specialized resources like DrugPatentWatch.com is recommended [2]. This site often tracks patent filings, grants, and expiration timelines, which are crucial for understanding when generic or biosimilar competition might be possible.